Survey: Canadians cite systemic barriers to legal medical cannabis
Posted October 17, 2020 11:00 am
Updated October 16, 2020 6:01 pm
1:58 Atlas collaborates with Harvard on medical cannabis research
WATCH (May 28, 2019): Edmonton cannabis company Atlas Growers announced a collaboration with Harvard Medical School. As Vinesh Pratap reports, the focus will be on researching the benefits of cannabis for medical use. Smaller font Descrease article font size -A
Larger font Increase article font size A +
Two years after the federal Cannabis Act came into effect, an advocacy group is calling for changes when it’s up for review this coming year.
A Medical Cannabis Patient Survey of about 1,000 patients using cannabis medicinally, by Medical Cannabis Canada, found that systemic barriers are preventing the majority of those patients from going through the legal medical market.
The results show that just 37 per cent of patients are obtaining a medical document (similar to a prescription) and that only 24 per cent of those without one consult a healthcare practitioner about their treatment, with the majority turning to other sources instead.
“Websites, friends and family, or even ‘bud-tenders’ or salespeople at recreational stores,” said Max Monahan-Ellison, Medical Cannabis Canada Board Member and MCPS Project lead.
Story continues below advertisement
“They are being diverted into other channels because the barriers to the actual legal medical market are so substantial that it’s really challenging to find the value as a patient.”